Information AboutNovartis |
: the sole Novartis pharmaceutical production facility in the United States.]] HISTORY Novartis was created in 1996 from the merger of Ciba-Geigy and Sandoz Laboratories , both Swiss companies with long histories. At the time it was said to be the largest corporate merger in history. Ciba-Geigy was formed in 1970 by the merger of '''J. R. Geigy''' (founded in Basel in 1758 ) and '''Ciba''' (founded in Basel in 1859 ). Considering the histories of the merger partners, the company's history spans almost 250 years. Company history at Novartis site Ciba-Geigy Johann Rudolf Geigy-Gemuseus (1733 – 1793) begins trading in 1758 in "materials, chemicals, dyes and drugs of all kinds" in Basel , Switzerland . Johann Rudolf Geigy-Merian (1830 – 1917) and Johann Muller-Pack acquire a site in Basel in 1857 , where they build a Dyewood mill and a dye extraction plant. Two years later, they begin the production of synthetic Fuchsine . In 1901 Geigy is transformed into a Public Limited Company and in 1914, the name of the company is changed to '''J.R. Geigy Ltd'''. In 1859 Alexander Clavel (1805 – 1873) takes up the production of fuchsine in his factory for Silk dyeing works in Basel. In 1864, a new site for the production of synthetic dyes is constructed, and in 1873, Clavel sells his dye factory to the new company Bindschedler & Busch. In 1884 Bindschedler & Busch is transformed into a joint-stock company with the name "Gesellschaft für Chemische Industrie Basel" (Company for Chemical Industry Basel). The abbreviation '''CIBA''' becomes so widespread that it was adopted as the company's name in 1945 . In 1925 J.R. Geigy Ltd. starts producing textile auxiliaries, an activity which Ciba takes up in 1928. Ciba and Geigy merged in 1971 to form Ciba‑Geigy Ltd., and this company merged with Sandoz in 1996 to form Novartis . Sandoz Sandoz is perhaps best known for synthesizing LSD in 1938 . This was later marketed under the trade name ''Delysid'' as a Psychiatric treatment from 1947 through the early 1960s. After the merger After the merger, Novartis reorganized its activities, and spun out its chemicals activities as Ciba Specialty Chemicals . In Spain ). Novartis combined its Agricultural division with that of AstraZeneca to create Syngenta in November 2000 . In 2003 , Novartis created Sandoz , a subsidiary that bundles its Generic Drug production, reusing the brand of one of its predecessor companies. On April 20 2006 Novartis acquired the California-based Chiron Corporation . Chiron was formerly divided into three units: Chiron Vaccines and Chiron Blood Testing, which now combine to form Novartis Vaccines and Diagnostics, and Chiron BioPharmaceuticals, to be integrated into Novartis Pharmaceuticals. CHALLENGE TO INDIA'S PATENT LAWS REFERENCES EXTERNAL LINKS
|
|
|